Chrysalis Podcast
Nick Northcott, Founder and Managing Partner of Chrysalis is featured at Stockhead's Unicorns Podcast, hosted by former broadcast journalist and PR veteran, Justin Kelly. In this podcast, Nick shares his story and how that motivated him to start Chrysalis in 2016 and takes us through the company's evolving journey with a mission to enable evidence-based care. Tune in to find out more about Chrysalis and the passion our specialist consulting team has to assist companies, hospitals, universities and medical research…
Biotechnology
Article by the Health Industry Hub Biotech News: A class action against an ASX-listed biotech has been filed at the Federal Court of Australia Nick Northcott, Chrysalis Managing Partner, said "Commercial biotech and medtech companies are working in a highly regulated environment, but this requires strong corporate governance as well as strong research governance. Often, not enough attention and scrutiny goes to the research governance frameworks in place for these companies." "Former Chief Scientist of Australian, Professor Ian Chubb, has…
Regular reports of biotech and medtech companies failing to disclose corporate and clinical data and breaching of clinical trials standards are of cause for concern. In an interview with Ausbiz, Nick Northcott, Chrysalis Managing Partner talks about the importance of having good corporate and also research governance in place to provide assurance for investors. Nick highlights the gap in the research integrity space faced by the biotech and medtech industries in Australia and raises the need for independent and impartial…
Clinical trials the big shift
Article by Nick Northcott* published on Hospital and Healthcare. For too long now, clinical trials in Australia have taken place to significantly varied standards. This has created a multitude of challenges for the medical system, with different hospitals and trial facilities working to methodologies and standards that are far from uniform, and therefore producing results that are difficult to compare, analyse and implement. Most importantly, the way the system has functioned has ultimately led to poorer patient outcomes. But a…
We love to welcome Stefanie Elbracht-Leong who is an important addition to our team with her role as Senior Consultant, Research Data Governance. In this critical role, Stefanie will support the development and delivery of research data governance services to Chrysalis clients across Australia, including hospitals, medical research institutes and other organisations. Stefanie comes with a diverse background supporting research in academic settings and healthcare for over a decade. She completed her PhD in experimental particle Physics at the University of Melbourne. She…
Nick Northcott, Managing Partner of Chrysalis joins a select group of AMR experts, biohackers, thinkers and innovators in a virtual AMR Solutions-Focused Workshop to explore what our world might look like in 2050 if we rallied around innovating and solving the challenges associated with Antimicrobial Resistance (AMR). This Antimicrobial Resistance Foresighting project, chaired by CSIRO’s Branwen Morgan, led by the Australian Academy of Technology and Engineering (ATSE) is a collaborative project with CSIRO (Commonwealth Scientific and Industrial Research Organisation) and…
Chrysalis is pleased to participate in the 2022 ARCS Annual Conference: Working together for success on 24 May 2022 at the International Convention Centre Sydney with Professor Nik Zeps, Partner of Chrysalis, participating as one of the speakers. The conference showcased an enormous breadth of topics related to the conduct of clinical trial activity in Australia. One of the core streams discussed at the conference is the reforms to clinical trial governance underway nationally and at the jurisdictions. At the…
Chrysalis is honoured to participate in the Australia-ASEAN Business Forum 2022, the premier trade and investment forum jointly hosted by the ten ASEAN Heads of Mission based in Canberra. Chrysalis Managing Partner, Nick Northcott was invited as one of the industry opinion leaders to highlight the opportunities and share his insights into the medical and health industries. “It was a pleasure to meet with the ASEAN ambassadors, commissioners and partners at the Forum and to share ideas about how we…
We are delighted to announce the promotion of Natalie Barber to Director, Clinical Operations for Chrysalis Clinical. Natalie joined the company in January 2022 and since then has delivered a number of critical projects with impeccable quality and dedication. Natalie leads the Clinical Operations overseeing the Research Strategy, Research Governance and the Research Integrity Business Unit's vision and goals to assist research organisations such as hospitals, universities and medical research institutions transform the way they work around research governance. Natalie…
We are delighted to share that Tara McLaren joined our growing Chrysalis Team as Senior Manager, Business Development. In this critical role, Tara will support the growth of Chrysalis Advisory and Chrysalis Clinical and will be leading our efforts in Research Integrity advisory services. Tara brings over 15 years of experience in the higher education and research sectors, supporting the identification, planning and delivery of high-quality research programs with a focus on translation to commercial and non-commercial outcomes. Tara has…